Quantcast

Latest Income statement Stories

2014-10-22 16:28:29

Net earnings per diluted share were $1.02 for the fourth quarter and $3.83 for fiscal year 2014; revenues were $812 million for the fourth quarter and $3 billion for the fiscal year; backlog rises 10 percent to $3.2 billion PALO ALTO, Calif., Oct. 22, 2014 /PRNewswire/ -- Varian Medical Systems (NYSE:VAR) today is reporting net earnings of $1.02 per diluted share in the fourth quarter of fiscal year 2014 and $3.83 for the full fiscal year 2014, which included about $33 million in...

2014-10-22 16:23:42

BATON ROUGE, La., Oct. 22, 2014 /PRNewswire/ -- Third quarter 2014 highlights: -- Adjusted earnings of $1.14 per share, up 5% versus third quarter 2013. -- Net sales grew 9% to $642.4 million versus third quarter 2013, with an adjusted EBITDA margin of 23%. -- Year to date cash flow from operations of $430.5 million, up 36% versus 2013 on lower working capital. -- Successful startup of Heavy Oil Upgrading capacity expansion in Bayport, TX. --...

2014-10-22 08:37:23

PITTSBURGH, Oct. 22, 2014 /PRNewswire/ -- -- 4% Sequential Revenue Growth; -- 4% Sequential Increase in Consultants on Billing; -- $0.20 Diluted Earnings Per Share from Continuing Operations; Mastech Holdings, Inc. (NYSE MKT: MHH), a national provider of Information Technology staffing services, announced today its financial results for the third quarter ended September 30, 2014. http://photos.prnewswire.com/prnvar/20100507/NE01385LOGO Third Quarter Results: Revenues from...

2014-10-22 08:31:20

- Third-Quarter Adjusted EPS Above Previous Guidance Range, Including Results From Discontinued Operations Related to Mylan Transaction - ABBOTT PARK, Ill., Oct. 22, 2014 /PRNewswire/ -- Abbott today announced financial results for the third quarter ended Sept. 30, 2014. -- Diluted EPS, excluding specified items, was $0.62 in the third quarter, representing growth of 12.7 percent, and above the previous guidance range of $0.59 to $0.61. This includes results from the...

2014-10-22 08:30:49

MARLBOROUGH, Mass., Oct. 22, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated sales of $1.846 billion during the third quarter ended September 30, 2014, compared to the company's guidance range for the quarter of $1.790 to $1.840 billion. This represents 7 percent operational revenue growth (constant currency basis, excluding divested businesses) and 6 percent revenue growth on a reported basis, all compared to the prior year period. The company achieved adjusted...

2014-10-22 08:24:02

NORTHFIELD, Ill., Oct. 22, 2014 /PRNewswire/ -- -- Net sales increased 3% to $491 million versus $476 million in the prior year quarter. -- Reported net income was $13.5 million or $0.59 per diluted share versus $20.4 million or $0.89 per diluted share in the prior year quarter. -- Adjusted net income*, was $15.6 million or $0.68 per diluted share, versus $18.6 million or $0.81 per diluted share in the prior year quarter. -- Polymer sales...

2014-10-21 16:31:48

(All amounts in U.S. dollars. Per share information based on diluted shares outstanding unless otherwise noted.) TORONTO, Oct. 21, 2014 /PRNewswire/ - Celestica Inc. (NYSE, TSX: CLS), a global leader in the delivery of end-to-end product lifecycle solutions, today announced financial results for the third quarter ended September 30, 2014. Third Quarter 2014 Highlights -- Revenue: $1.423 billion, within the range of our guidance of $1.40 to $1.50 billion (announced July 24,...

2014-10-21 16:28:38

BEDFORD, Mass., Oct. 21, 2014 /PRNewswire/ -- Aware, Inc. (NASDAQ: AWRE), a leading supplier of biometrics software and services, today reported financial results for its third quarter ended September 30, 2014. Revenue for the third quarter of 2014 was $6.0 million, an increase of 40% compared to $4.3 million in the same quarter last year. Operating income in the third quarter of 2014 was $4.1 million compared to $1.0 million in the third quarter of 2013. Higher operating income in...

2014-10-21 16:28:30

UNION CITY, Calif., Oct. 21, 2014 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today reported financial results for the second fiscal quarter ended September 30, 2014. Second quarter overview: -- Revenues of $53.9 million, up 18% over last year's comparable quarter. -- Diluted EPS of $0.24, up 33% over last year's comparable quarter. Revenues highlights: -- Service revenues from Abaxis...

2014-10-21 12:24:41

BEIJING, Oct. 21, 2014 /PRNewswire/ -- Huaneng Power International, Inc. ("HPI", the "Company") (NYSE: HNP; HKEx: 902; SSE: 600011) today announced its unaudited results for the nine months ended September 30, 2014. Under the PRC GAAP, the Company realized consolidated operating revenue of RMB 94.627 billion for the first three quarters of 2014, representing a decrease of 4.65% over the same period last year. Consolidated net profit attributable to the shareholders of the Company was...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.